ZA200902943B - Agonist TrkB antibodies and uses thereof - Google Patents

Agonist TrkB antibodies and uses thereof

Info

Publication number
ZA200902943B
ZA200902943B ZA200902943A ZA200902943A ZA200902943B ZA 200902943 B ZA200902943 B ZA 200902943B ZA 200902943 A ZA200902943 A ZA 200902943A ZA 200902943 A ZA200902943 A ZA 200902943A ZA 200902943 B ZA200902943 B ZA 200902943B
Authority
ZA
South Africa
Prior art keywords
trkb antibodies
agonist
agonist trkb
antibodies
trkb
Prior art date
Application number
ZA200902943A
Other languages
English (en)
Inventor
Yan Wang
Steven B Cohen
Marc Nasoff
Original Assignee
Irm Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Irm Llc filed Critical Irm Llc
Publication of ZA200902943B publication Critical patent/ZA200902943B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/75—Agonist effect on antigen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200902943A 2006-11-09 2009-04-29 Agonist TrkB antibodies and uses thereof ZA200902943B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85816906P 2006-11-09 2006-11-09

Publications (1)

Publication Number Publication Date
ZA200902943B true ZA200902943B (en) 2010-05-26

Family

ID=39365312

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200902943A ZA200902943B (en) 2006-11-09 2009-04-29 Agonist TrkB antibodies and uses thereof

Country Status (27)

Country Link
US (1) US20100150914A1 (fr)
EP (1) EP2087007A2 (fr)
JP (1) JP2010509354A (fr)
KR (1) KR20090088896A (fr)
CN (1) CN101573381A (fr)
AR (1) AR063640A1 (fr)
AU (1) AU2007316418A1 (fr)
BR (1) BRPI0719000A2 (fr)
CA (1) CA2669205A1 (fr)
CL (1) CL2007003236A1 (fr)
CO (1) CO6180432A2 (fr)
CR (1) CR10779A (fr)
DO (1) DOP2009000102A (fr)
EA (1) EA200970469A1 (fr)
EC (1) ECSP099392A (fr)
IL (1) IL198468A0 (fr)
MA (1) MA30922B1 (fr)
MX (1) MX2009004881A (fr)
NI (1) NI200900081U (fr)
NO (1) NO20092217L (fr)
PE (1) PE20081168A1 (fr)
RU (1) RU2009121641A (fr)
SM (1) SMAP200900040A (fr)
TN (1) TN2009000181A1 (fr)
TW (1) TW200829270A (fr)
WO (1) WO2008058127A2 (fr)
ZA (1) ZA200902943B (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010004494A (es) * 2007-10-23 2010-08-30 Novartis Ag Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
CA2712298C (fr) 2008-01-17 2015-11-24 Irm Llc Anticorps anti-trkb ameliores
US8748493B2 (en) * 2009-03-20 2014-06-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Inhibitors of cathepsin S for prevention or treatment of obesity-associated disorders
GB2491106A (en) * 2011-05-18 2012-11-28 Univ Basel Antibodies against tropomyosin-related kinase B receptors
WO2013083826A2 (fr) * 2011-12-09 2013-06-13 Novo Nordisk A/S Agonistes du glp-1
CN102901815B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体816/817位酪氨酸位点活性的ELISA试剂盒及其使用方法
CN102944674B (zh) * 2012-11-05 2014-10-22 武汉远征世纪制药有限公司 一种检测TrkB受体pan-Tyr位点活性的ELISA试剂盒及其使用方法
ES2936810T3 (es) 2014-05-16 2023-03-22 Pfizer Anticuerpos biespecíficos con interfaces CH1-CL de ingeniería
CN104524568B (zh) * 2015-01-08 2018-04-20 中国人民解放军第二军医大学 一种治疗肥胖症的药物组合物及其应用
CA2993645A1 (fr) 2015-07-28 2017-02-02 Otonomy, Inc. Compositions d'agoniste trkb ou trkc et methodes de traitement de troubles otiques
CA3005491A1 (fr) * 2015-11-17 2017-05-26 Glaxosmithkline Intellectual Property Development Limited Agonistes de liaison utilises pour le traitement de troubles neurologiques et d'autres troubles
US9914781B1 (en) 2016-11-08 2018-03-13 Glaxosmithkline Intellectual Property Development Limited Binding agonist for treatment of neurological and other disorders
SG11201909708VA (en) 2017-04-21 2019-11-28 Mellitus Llc Methods and antibodies for diabetes-related applications
US10793634B2 (en) * 2017-06-09 2020-10-06 Boehringer Ingelheim International Gmbh Anti-TrkB antibodies
WO2019108662A1 (fr) * 2017-11-30 2019-06-06 Regeneron Pharmaceuticals, Inc. Anticorps monoclonaux anti-trkb et leurs procédés d'utilisation
CN112272677B (zh) 2018-02-26 2024-10-29 米纳瓦生物技术公司 使用抗muc1＊抗体的诊断方法
CN110818797B (zh) * 2018-08-09 2022-11-04 东莞市朋志生物科技有限公司 一种抗人ca153蛋白的重组抗体
JP7633397B2 (ja) 2020-10-21 2025-02-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 眼の疾患の処置のための二重特異性抗ＶＥＧＦ及び抗ＴｒｋＢ結合分子
WO2023125485A1 (fr) * 2021-12-28 2023-07-06 4B Technologies (Beijing) Co., Limited Anticorps trkb et son application

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0436597B1 (fr) 1988-09-02 1997-04-02 Protein Engineering Corporation Production et selection de proteines de liaison diversifiees de recombinaison
WO1991010737A1 (fr) 1990-01-11 1991-07-25 Molecular Affinities Corporation Production d'anticorps utilisant des librairies de genes
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
DK0580737T3 (da) 1991-04-10 2004-11-01 Scripps Research Inst Heterodimere receptorbiblioteker ved anvendelse af phagemider
ES2341666T3 (es) 1991-12-02 2010-06-24 Medimmune Limited Produccion de autoanticuerpos de repertorios de segmentos de anticue rpos expresados en la superficie de fagos.
EP0733070A1 (fr) 1993-12-08 1996-09-25 Genzyme Corporation Procede de generation d'anticorps specifiques
PT1231268E (pt) 1994-01-31 2005-11-30 Univ Boston Bancos de anticorpos policlonais
US5601820A (en) * 1994-07-07 1997-02-11 Children's Hospital Of Philadelphia Compositions and methods of making and using human full length TRK-B
WO2006133164A2 (fr) * 2005-06-06 2006-12-14 Wyeth Anticorps monoclonaux anti-trkb et utilisations de ceux-ci
EP1988920A1 (fr) * 2006-02-02 2008-11-12 Rinat Neuroscience Corp. Procédés de traitement de l'obésité par administration d'un antagoniste trkb
EP1988923A1 (fr) * 2006-02-02 2008-11-12 Rinat Neuroscience Corp. Procédés de traitement de perte de poids non recherchée ou de troubles de l'alimentation par administration d'un agoniste trkb

Also Published As

Publication number Publication date
AU2007316418A1 (en) 2008-05-15
CN101573381A (zh) 2009-11-04
NI200900081U (es) 2010-03-16
IL198468A0 (en) 2011-08-01
NO20092217L (no) 2009-06-09
TW200829270A (en) 2008-07-16
CR10779A (es) 2009-07-03
WO2008058127A3 (fr) 2008-10-02
CO6180432A2 (es) 2010-07-19
SMAP200900040A (it) 2010-01-19
MA30922B1 (fr) 2009-11-02
WO2008058127A9 (fr) 2008-08-21
US20100150914A1 (en) 2010-06-17
WO2008058127A2 (fr) 2008-05-15
EP2087007A2 (fr) 2009-08-12
PE20081168A1 (es) 2008-09-22
MX2009004881A (es) 2009-05-21
CA2669205A1 (fr) 2008-05-15
JP2010509354A (ja) 2010-03-25
CL2007003236A1 (es) 2008-06-13
EA200970469A1 (ru) 2010-04-30
DOP2009000102A (es) 2010-10-31
KR20090088896A (ko) 2009-08-20
AR063640A1 (es) 2009-02-04
TN2009000181A1 (en) 2010-10-18
RU2009121641A (ru) 2010-12-20
ECSP099392A (es) 2009-07-31
BRPI0719000A2 (pt) 2013-12-10

Similar Documents

Publication Publication Date Title
ZA200902943B (en) Agonist TrkB antibodies and uses thereof
ZA200810311B (en) Anti-NKG2A antibodies and uses thereof
ZA200900351B (en) Prlr-specific antibody and uses thereof
IL240245A (en) 5t4 antibodies and their uses
LT2436696T (lt) Anti-beta-amiloido antikūnas ir jo panaudojimas
IL222922A (en) Antibodies against neurophilin-1 and their use
IL194266A0 (en) Anti-igf-ir antibodies and uses thereof
IL205355A0 (en) Anti- hepcidin antibodies and uses thereof
IL200012A0 (en) Anti-robo4 antibodies and uses therefor
IL192419A0 (en) Anti-ephb4 antibodies and methods using same
IL193477A0 (en) Cb1 antagonists and inverse agonists
IL231891A0 (en) Anti-2ephriinb antibodies and methods of using them
EP2077325A4 (fr) Anticorps monoclonal et son utilisation
ZA201103941B (en) Anti-ferroportin 1 monoclonal antibodies and uses thereof
HK1128034A (en) Agonist trkb antibodies and uses thereof
ZA200806053B (en) Anti-EphB4 antibodies and methods using same
ZA200905136B (en) Anti-robo4 antibodies and uses therefor
GB0507219D0 (en) Antibody and uses thereof
GB0507272D0 (en) Antibody and uses thereof